Journal article
Development of an optimised method for the analysis of human blood plasma samples by atmospheric solids analysis probe mass spectrometry
- Abstract:
- Analysis of small-molecule metabolites in plasma has the potential for development as a clinical diagnostic and prognostic tool. Atmospheric solids analysis probe mass spectrometry (ASAP-MS) is capable of performing rapid metabolite and small molecule fingerprinting, and has the potential for use in a clinical setting. Combining ASAP-MS data with a predictive model could provide clinicians with a rapid patient risk metric, anticipating disease progression and response to treatment, and thereby aiding in treatment decisions. In order to develop predictive models, experimental errors and uncertainties must be minimised, requiring a robust experimental protocol. In the present study we have performed ASAP-MS measurements on plasma samples from patients recruited for two prospective clinical studies: the Oxford Acute Myocardial Infarction (OxAMI) study; and the Oxford Abdominal Aortic Aneurysm (OxAAA) study. Through a carefully designed series of measurements, we have optimised the method of sample introduction, together with a number of key instrument and data acquisition parameters. Following the optimisation process, we are consistently able to record high quality mass spectra for plasma samples. Typical coefficients of variation for individual mass peaks are in the range from 20%–50%, overlapping with those obtained using more sophisticated LC-MS approaches. The measurement protocol optimises mass spectral quality and reproducibility, while retaining the simplicity of measurement required for use in a clinical setting. While the protocol was developed using plasma samples from two specific patient cohorts, the method can be generalised to any plasma measurements.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.2MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.ijms.2024.117386
Authors
+ Wellcome Trust
More from this funder
- Funder identifier:
- https://ror.org/029chgv08
- Grant:
- 218514/Z/19/Z
- Publisher:
- Elsevier
- Journal:
- International Journal of Mass Spectrometry More from this journal
- Volume:
- 508
- Article number:
- 117386
- Publication date:
- 2024-12-10
- Acceptance date:
- 2024-12-04
- DOI:
- EISSN:
-
1873-2798
- ISSN:
-
1387-3806
- Language:
-
English
- Keywords:
- Pubs id:
-
1635863
- UUID:
-
uuid_640824bc-6c99-4fdb-b81a-627d25cd22a3
- Local pid:
-
pubs:1635863
- Source identifiers:
-
W4389668265
- Deposit date:
-
2025-12-08
- ARK identifier:
Terms of use
- Copyright holder:
- Eardley-Brunt et al
- Copyright date:
- 2024
- Rights statement:
- © 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record